Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

23 févr. 2026 08h30 HE | Source: PharmAla Biotech

PharmAla To Supply Amsterdam UMC with LaNeo™ MDMA, Including Development of New Single-Capsule Stability Data

PharmAla to supply University of Amsterdam with LaNeo MDMA for a clinical trial, generating new stability data for blister packs in the process
23 févr. 2026 08h00 HE | Source: Phathom Pharmaceuticals

Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences

FLORHAM PARK, N.J., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for...
19 févr. 2026 07h00 HE | Source: Regeneron Pharmaceuticals, Inc.

Garetosmab Biologics License Application Accepted for FDA Priority Review for the Treatment of Fibrodysplasia Ossificans Progressiva (FOP)

FOP is an ultra-rare genetic disorder characterized by abnormal bone formation that infiltrates muscles, tendons, ligaments and other connective tissues, resulting in significant disability If...
18 févr. 2026 08h30 HE | Source: Oncotelic Therapeutics, Inc.

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Key IP Portfolio Advancements Align with Biotech Asset Trend

NEW YORK, Feb. 18, 2026 (GLOBE NEWSWIRE) -- via BioMedWire -- Oncotelic Therapeutics Inc. (OTCQB: OTLC) today announces its placement in an editorial published by BioMedWire (BMW), one of 75+ brands...
18 févr. 2026 06h47 HE | Source: Research and Markets

Longevity Market Report 2026-2036: Advances in AI, Genomics and Regenerative Medicine Are Accelerating Developments

Dublin, Feb. 18, 2026 (GLOBE NEWSWIRE) -- The "Longevity Market Report 2026-2036" report has been added to ResearchAndMarkets.com's offering.Overall world revenue for Longevity Market will surpass...
17 févr. 2026 11h32 HE | Source: Research and Markets

U.S. Orphan Drug Market Report 2026: A $200 Billion Opportunity by 2031 - Indication, Company, Trial Phase, Marketed Status of 1400 Drugs, Drug Sales of 150 Drugs, Pricing and Dosage of 400 Drugs

Dublin, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The "U.S. Orphan Drug Market, Drug Sales, Price, Dosage & Clinical Pipeline Insight 2031" drug pipelines has been added to ResearchAndMarkets.com's...
17 févr. 2026 08h00 HE | Source: MediWound Ltd.

MediWound to Present at Upcoming Investor Conferences

MediWound to Present at Upcoming Investor Conferences YAVNE, Israel, February 17, 2026 -- MediWound Ltd. (Nasdaq: MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair,...
17 févr. 2026 07h28 HE | Source: Nutriband Inc.

Nutriband Signs Exclusive Distribution Agreement with Innomedica for AVERSA Fentanyl and all Sports Tape products for Costa Rica

New Strategic Partnership
16 févr. 2026 06h30 HE | Source: Research and Markets

India Pharmaceutical Directory 2026: Essential Business Intelligence for Sourcing, Selling and Expanding Across India's Pharma and Biotech Value Chain

Dublin, Feb. 16, 2026 (GLOBE NEWSWIRE) -- The "Indian Pharmaceutical Directory" directory has been added to ResearchAndMarkets.com's offering.The Indian pharmaceutical industry is undergoing...
12 févr. 2026 11h27 HE | Source: Research and Markets

3 Day Pharma Mini MBA Training Course: Translate Your Learning Into New Behaviours and Improvements (ONLINE EVENT: Mar 18th - Mar 20th, 2026)

Dublin, Feb. 12, 2026 (GLOBE NEWSWIRE) -- The "The Pharma Mini MBA Training Course (Mar 18th - Mar 20th, 2026)" training has been added to ResearchAndMarkets.com's offering. Working in the...

Page suivante